Agilent Technologies (NYSE:A) Issues FY25 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY25 earnings guidance on Monday. The company provided EPS guidance of $5.54-5.61 for the period, compared to the consensus EPS estimate of $5.65. The company issued revenue guidance of $6.79-6.87 billion, compared to the consensus revenue estimate of $6.82 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Stock Up 2.8 %

A stock opened at $138.11 on Thursday. The firm has a market capitalization of $39.68 billion, a PE ratio of 28.65, a P/E/G ratio of 5.91 and a beta of 1.07. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies has a twelve month low of $124.10 and a twelve month high of $155.35. The stock’s 50 day moving average is $137.72 and its 200-day moving average is $137.43.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.72%. The ex-dividend date of this dividend is Tuesday, December 31st. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is 20.54%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Wells Fargo & Company started coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price on the stock. Citigroup increased their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. StockNews.com lowered Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday. UBS Group increased their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research note on Monday, August 26th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $143.40.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.33% of the stock is currently owned by insiders.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.